Literature DB >> 11787760

Brain-gut axis in gastroprotection by leptin and cholecystokinin against ischemia-reperfusion induced gastric lesions.

T Brzozowski1, P C Konturek, R Pajdo, S Kwiecień, A Ptak, Z Sliwowski, D Drozdowicz, M Pawlik, S J Konturek, E G Hahn.   

Abstract

Leptin, a product of ob gene controlling food intake, has recently been detected in the stomach and shown to be released by CCK and implicated in gastroprotection against various noxious agents but it is unknown whether centrally applied leptin influences ischemia-reperfusion (I/R)-induced gastric erosions that progress into deeper gastric ulcerations. In this study we compared the effects of leptin and CCK-8 applied intracerebroventricularly (i.c.v.) or intraperitoneally (i.p.) on gastric mucosal lesions induced by I/R and topical application of 75% ethanol. Several major series of Wistar rats were used to examine the effects of leptin and CCK applied centrally on gastroprotection against I/R and ethanol in rats with A) vagotomy by cutting of vagal nerves, B) suppression of NO-synthase with L-NNA (20 mg/kg i.p.), C) inactivation of sensory nerves by capsaicin (125 mg/kg s.c.) and D) inhibition of CGRP receptors with CGR(8-37) (100 microg/kg i.p.) applied with or without the i.c.v. pretreatment with leptin or CCK-8. Rats were anesthetized 1 h after ethanol administration or at 3 h and 3 days upon the end of ischemia to measure the gastric blood flow (GBF) and then to determine the area of gastric lesions by planimetry. Blood was withdrawn for the measurement of plasma leptin and gastrin levels by radioimmunoassay (RIA). Leptin (0.1-20 microg/kg i.p.) dose-dependently attenuated gastric lesions induced by 75% ethanol and I/R; the dose reducing these lesions by 50% (ED50) was 8 microg/kg and 6 microg/kg, respectively and this protective effect was similar to that obtained with CCK-8 applied in a standard dose of 10 microg/kg i.p. This protective effect of leptin was accompanied by a significant increase in GBF and plasma gastrin levels whereas CCK-8 increased plasma leptin levels but failed to affect plasma gastrin levels. Leptin and CCK-8 applied i.c.v. in a dose of 625 ng/rat reduced significantly the area of I/R induced gastric lesions and raised the GBF and plasma leptin levels with the extent similar to those achieved with peripheral administration of leptin or CCK-8 (10 microg/kg i.p.). The protective and hyperemic effects of centrally administered leptin or CCK-8 (625 ng/rat i.c.v.) were completely abolished by vagotomy and significantly attenuated by sensory denervation with capsaicin or by CGRP antagonist, CGRP(8-37). The pretreatment with L-NNA to inhibit NO-synthase activity attenuated significantly the protective and hyperemic effects of CCK but not those of leptin while capsaicin denervation counteracted leptin-induced protection and rise in the GBF but attenuated significantly those of CCK. We conclude that: 1) central leptin exerts a potent gastroprotective activity against I/R-induced gastric erosions that progress into deeper gastric lesions and this protection depends upon vagal activity and sensory nerves and involves hyperemia probably mediated by NO and 2) leptin mimics the gastroprotective effect of CCK and may be implicated in the protective and hyperemic actions of this peptide against mucosal damage evoked by I/R.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11787760

Source DB:  PubMed          Journal:  J Physiol Pharmacol        ISSN: 0867-5910            Impact factor:   3.011


  10 in total

1.  Leptin-induced cardioprotection involves JAK/STAT signaling that may be linked to the mitochondrial permeability transition pore.

Authors:  Christopher C T Smith; Richard A Dixon; Abigail M Wynne; Louise Theodorou; Sang-Ging Ong; Sapna Subrayan; Sean M Davidson; Derek J Hausenloy; Derek M Yellon
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-07-23       Impact factor: 4.733

Review 2.  Brainstem neuropeptides and vagal protection of the gastric mucosal against injury: role of prostaglandins, nitric oxide and calcitonin-gene related peptide in capsaicin afferents.

Authors:  Y Tache
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

3.  Mechanisms of action of leptin in preventing gastric ulcer.

Authors:  Edward O Adeyemi; Salim A Bastaki; Irwin S Chandranath; Mohammed Y Hasan; Mohammed Fahim; Abdu Adem
Journal:  World J Gastroenterol       Date:  2005-07-21       Impact factor: 5.742

4.  Variation of pathways and network profiles reveals the differential pharmacological mechanisms of each effective component to treat middle cerebral artery ischemia-reperfusion mice.

Authors:  HaiXia Dang; KangNing Li; YaNan Yu; YingYing Zhang; Jun Liu; PengQian Wang; Bing Li; HaiNan Wang; Haixia Li; Zhong Wang; YongYan Wang
Journal:  Exp Biol Med (Maywood)       Date:  2015-07-12

5.  Leptin, the obesity-associated hormone, exhibits direct cardioprotective effects.

Authors:  C C T Smith; M M Mocanu; S M Davidson; A M Wynne; J C Simpkin; D M Yellon
Journal:  Br J Pharmacol       Date:  2006-07-17       Impact factor: 8.739

6.  Effect of leptin on renal ischemia-reperfusion damage in rats.

Authors:  S Erkasap; N Erkasap; T Koken; A Kahraman; K Uzuner; N Yazihan; E Ates
Journal:  J Physiol Biochem       Date:  2004-06       Impact factor: 4.158

Review 7.  Cholecystokinin-induced gastroprotection: a review of current protective mechanisms.

Authors:  Sonlee D West; David W Mercer
Journal:  Dig Dis Sci       Date:  2004-03       Impact factor: 3.199

8.  Effects of leptin on stress-induced changes of caspases in rat gastric mucosa.

Authors:  Sevim Ercan; Ciğdem Ozer; Murat Taş; Deniz Erdoğan; Aydan Babül
Journal:  J Gastroenterol       Date:  2007-06-29       Impact factor: 6.772

Review 9.  Gut-Brain Axis in Gastric Mucosal Damage and Protection.

Authors:  Dolores Sgambato; Annalisa Capuano; Maria Giuseppa Sullo; Agnese Miranda; Alessandro Federico; Marco Romano
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

Review 10.  Role of Leptin in the Digestive System.

Authors:  Min-Hyun Kim; Hyeyoung Kim
Journal:  Front Pharmacol       Date:  2021-04-12       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.